Skip to content
value.today

AbbVie Inc. vs Pharmanutra S.p.A.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $593 M for Pharmanutra S.p.A., 867 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Pharmanutra S.p.A.). Pharmanutra S.p.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • AbbVie Inc. had more revenue: $61.2 B against $148 M for Pharmanutra S.p.A., both in the year to December 2025.
  • AbbVie Inc. earned more: net income of $4.2 B against $23 M for Pharmanutra S.p.A.
  • Pharmanutra S.p.A. keeps more of each dollar of sales: a net margin of 15.2% against 6.9% for AbbVie Inc.
  • Pharmanutra S.p.A.'s revenue grew faster in its latest fiscal year: +18.8% against +8.6% for AbbVie Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0981952933902020202120222023202420252026AbbVie Inc. 390Pharmanutra S.p.A. 233

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$31B$46B$61B201720182019202020212022202320242025AbbVie Inc. $61BPharmanutra S.p.A. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Pharmanutra S.p.A.
PHN.MI
Profile
Country🇺🇸 USA🇮🇹 Italy
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded2013—
Size
Market cap$514.0 B$593 M*
Revenue$61.2 B$148 M
Net income$4.2 B▲ best$23 M
Employees57,000—
Valuation
P/E ratio49.7×—
Price to sales7.8×—
Free cash flow yield3.5%—
Profitability
Gross margin70.2%—
Operating margin24.6%26.0%▲ best
Net margin6.9%15.2%▲ best
Return on equity—30.4%
Return on invested capital16.0%—
Growth
Revenue growth8.6%18.8%▲ best
Revenue growth, 3 years a year1.8%—
Earnings per share growth-1.3%25.9%▲ best
Financial strength
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Pharmanutra S.p.A.?

AbbVie Inc. is the larger company by market value: $514.0 B against $593 M for Pharmanutra S.p.A., 867 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Pharmanutra S.p.A.). Pharmanutra S.p.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, AbbVie Inc. or Pharmanutra S.p.A.?

AbbVie Inc. had more revenue: $61.2 B against $148 M for Pharmanutra S.p.A., both in the year to December 2025. AbbVie Inc. earned more: net income of $4.2 B against $23 M for Pharmanutra S.p.A.

Which is more profitable, AbbVie Inc. or Pharmanutra S.p.A.?

Pharmanutra S.p.A. keeps more of each dollar of sales: a net margin of 15.2% against 6.9% for AbbVie Inc.

Which is growing faster, AbbVie Inc. or Pharmanutra S.p.A.?

Pharmanutra S.p.A.'s revenue grew faster in its latest fiscal year: +18.8% against +8.6% for AbbVie Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.